270 related articles for article (PubMed ID: 27958883)
1. Glutaredoxin-1 Deficiency Causes Fatty Liver and Dyslipidemia by Inhibiting Sirtuin-1.
Shao D; Han J; Hou X; Fry J; Behring JB; Seta F; Long MT; Roy HK; Cohen RA; Matsui R; Bachschmid MM
Antioxid Redox Signal; 2017 Aug; 27(6):313-327. PubMed ID: 27958883
[TBL] [Abstract][Full Text] [Related]
2. Hepatic SIRT1 attenuates hepatic steatosis and controls energy balance in mice by inducing fibroblast growth factor 21.
Li Y; Wong K; Giles A; Jiang J; Lee JW; Adams AC; Kharitonenkov A; Yang Q; Gao B; Guarente L; Zang M
Gastroenterology; 2014 Feb; 146(2):539-49.e7. PubMed ID: 24184811
[TBL] [Abstract][Full Text] [Related]
3. Oxidized GAPDH transfers S-glutathionylation to a nuclear protein Sirtuin-1 leading to apoptosis.
Mustafa Rizvi SH; Shao D; Tsukahara Y; Pimentel DR; Weisbrod RM; Hamburg NM; McComb ME; Matsui R; Bachschmid MM
Free Radic Biol Med; 2021 Oct; 174():73-83. PubMed ID: 34332079
[TBL] [Abstract][Full Text] [Related]
4. Glutathione adducts induced by ischemia and deletion of glutaredoxin-1 stabilize HIF-1α and improve limb revascularization.
Watanabe Y; Murdoch CE; Sano S; Ido Y; Bachschmid MM; Cohen RA; Matsui R
Proc Natl Acad Sci U S A; 2016 May; 113(21):6011-6. PubMed ID: 27162359
[TBL] [Abstract][Full Text] [Related]
5. Redox Regulation
Matsui R; Ferran B; Oh A; Croteau D; Shao D; Han J; Pimentel DR; Bachschmid MM
Antioxid Redox Signal; 2020 Apr; 32(10):677-700. PubMed ID: 31813265
[No Abstract] [Full Text] [Related]
6. IL-33 induction and signaling are controlled by glutaredoxin-1 in mouse macrophages.
Weinberg EO; Ferran B; Tsukahara Y; Hatch MMS; Han J; Murdoch CE; Matsui R
PLoS One; 2019; 14(1):e0210827. PubMed ID: 30682073
[TBL] [Abstract][Full Text] [Related]
7. Involvement of mammalian sirtuin 1 in the action of ethanol in the liver.
You M; Liang X; Ajmo JM; Ness GC
Am J Physiol Gastrointest Liver Physiol; 2008 Apr; 294(4):G892-8. PubMed ID: 18239056
[TBL] [Abstract][Full Text] [Related]
8. A redox-resistant sirtuin-1 mutant protects against hepatic metabolic and oxidant stress.
Shao D; Fry JL; Han J; Hou X; Pimentel DR; Matsui R; Cohen RA; Bachschmid MM
J Biol Chem; 2014 Mar; 289(11):7293-306. PubMed ID: 24451382
[TBL] [Abstract][Full Text] [Related]
9. Sirt1 mediates the effect of the heme oxygenase inducer, cobalt protoporphyrin, on ameliorating liver metabolic damage caused by a high-fat diet.
Liu X; Gao Y; Li M; Geng C; Xu H; Yang Y; Guo Y; Jiao T; Fang F; Chang Y
J Hepatol; 2015 Sep; 63(3):713-21. PubMed ID: 26026874
[TBL] [Abstract][Full Text] [Related]
10. Glutaredoxin-1 promotes lymphangioleiomyomatosis progression through inhibiting Bim-mediated apoptosis via COX2/PGE2/ERK pathway.
Feng Y; Li T; Li Y; Lin Z; Han X; Pei X; Zhang Y; Li F; Yang J; Shao D; Li C
Clin Transl Med; 2023 Jul; 13(7):e1333. PubMed ID: 37478294
[TBL] [Abstract][Full Text] [Related]
11. SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism.
Ponugoti B; Kim DH; Xiao Z; Smith Z; Miao J; Zang M; Wu SY; Chiang CM; Veenstra TD; Kemper JK
J Biol Chem; 2010 Oct; 285(44):33959-70. PubMed ID: 20817729
[TBL] [Abstract][Full Text] [Related]
12. Scopolin ameliorates high-fat diet induced hepatic steatosis in mice: potential involvement of SIRT1-mediated signaling cascades in the liver.
Yoo A; Narayan VP; Hong EY; Whang WK; Park T
Sci Rep; 2017 May; 7(1):2251. PubMed ID: 28533555
[TBL] [Abstract][Full Text] [Related]
13. SIRT1 activation by methylene blue, a repurposed drug, leads to AMPK-mediated inhibition of steatosis and steatohepatitis.
Shin SY; Kim TH; Wu H; Choi YH; Kim SG
Eur J Pharmacol; 2014 Mar; 727():115-24. PubMed ID: 24486702
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of miR-192 causes hepatic steatosis and lipid accumulation by inducing SREBF1: Novel mechanism for bisphenol A-triggered non-alcoholic fatty liver disease.
Lin Y; Ding D; Huang Q; Liu Q; Lu H; Lu Y; Chi Y; Sun X; Ye G; Zhu H; Wei J; Dong S
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):869-882. PubMed ID: 28483554
[TBL] [Abstract][Full Text] [Related]
15. Tangshen formula attenuates hepatic steatosis by inhibiting hepatic lipogenesis and augmenting fatty acid oxidation in db/db mice.
Kong Q; Zhang H; Zhao T; Zhang W; Yan M; Dong X; Li P
Int J Mol Med; 2016 Dec; 38(6):1715-1726. PubMed ID: 27840945
[TBL] [Abstract][Full Text] [Related]
16. Gα12 ablation exacerbates liver steatosis and obesity by suppressing USP22/SIRT1-regulated mitochondrial respiration.
Kim TH; Yang YM; Han CY; Koo JH; Oh H; Kim SS; You BH; Choi YH; Park TS; Lee CH; Kurose H; Noureddin M; Seki E; Wan YY; Choi CS; Kim SG
J Clin Invest; 2018 Dec; 128(12):5587-5602. PubMed ID: 30300140
[TBL] [Abstract][Full Text] [Related]
17. Flavonones from
Guo WW; Wang X; Chen XQ; Ba YY; Zhang N; Xu RR; Zhao WW; Wu X
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30154382
[TBL] [Abstract][Full Text] [Related]
18. Thyrotropin increases hepatic triglyceride content through upregulation of SREBP-1c activity.
Yan F; Wang Q; Lu M; Chen W; Song Y; Jing F; Guan Y; Wang L; Lin Y; Bo T; Zhang J; Wang T; Xin W; Yu C; Guan Q; Zhou X; Gao L; Xu C; Zhao J
J Hepatol; 2014 Dec; 61(6):1358-64. PubMed ID: 25016220
[TBL] [Abstract][Full Text] [Related]
19. Dietary α-lactalbumin induced fatty liver by enhancing nuclear liver X receptor αβ/sterol regulatory element-binding protein-1c/PPARγ expression and minimising PPARα/carnitine palmitoyltransferase-1 expression and AMP-activated protein kinase α phosphorylation associated with atherogenic dyslipidaemia, insulin resistance and oxidative stress in Balb/c mice.
López-Oliva ME; Garcimartin A; Muñoz-Martínez E
Br J Nutr; 2017 Dec; 118(11):914-929. PubMed ID: 29173234
[TBL] [Abstract][Full Text] [Related]
20. Lack of SIRT1 (Mammalian Sirtuin 1) activity leads to liver steatosis in the SIRT1+/- mice: a role of lipid mobilization and inflammation.
Xu F; Gao Z; Zhang J; Rivera CA; Yin J; Weng J; Ye J
Endocrinology; 2010 Jun; 151(6):2504-14. PubMed ID: 20339025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
